Premier Fund Managers Ltd Acquires Shares of 16,234 Astrana Health, Inc. (NASDAQ:ASTH)

Premier Fund Managers Ltd bought a new stake in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 16,234 shares of the company's stock, valued at approximately $918,000.

Other large investors also recently modified their holdings of the company. GAMMA Investing LLC acquired a new stake in shares of Astrana Health in the 3rd quarter valued at about $34,000. Nisa Investment Advisors LLC acquired a new position in Astrana Health during the third quarter worth $35,000. KBC Group NV acquired a new stake in Astrana Health in the 3rd quarter valued at $70,000. Quest Partners LLC acquired a new position in shares of Astrana Health during the 3rd quarter worth about $133,000. Finally, Central Pacific Bank Trust Division bought a new position in shares of Astrana Health in the 3rd quarter valued at about $160,000. 52.77% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages recently commented on ASTH. BTIG Research increased their price target on Astrana Health from $60.00 to $70.00 and gave the company a "buy" rating in a research report on Thursday, October 3rd. Robert W. Baird boosted their target price on shares of Astrana Health from $67.00 to $86.00 and gave the stock an "outperform" rating in a report on Wednesday, November 13th. Truist Financial increased their price target on shares of Astrana Health from $50.00 to $59.00 and gave the company a "buy" rating in a research note on Friday, August 9th. Stifel Nicolaus boosted their price objective on shares of Astrana Health from $48.00 to $60.00 and gave the stock a "buy" rating in a research note on Thursday, August 1st. Finally, KeyCorp initiated coverage on Astrana Health in a report on Friday, October 11th. They set a "sector weight" rating for the company. One analyst has rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Buy" and an average target price of $65.17.

Astrana Health Stock Performance

Shares of Astrana Health stock traded down $0.35 on Wednesday, hitting $40.58. The stock had a trading volume of 69,452 shares, compared to its average volume of 208,051. The stock has a market cap of $2.28 billion, a price-to-earnings ratio of 31.48, a price-to-earnings-growth ratio of 1.89 and a beta of 1.24. The business's 50 day moving average is $54.77 and its two-hundred day moving average is $47.86. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60. Astrana Health, Inc. has a twelve month low of $32.04 and a twelve month high of $63.20.

Astrana Health (NASDAQ:ASTH - Get Free Report) last posted its earnings results on Thursday, November 7th. The company reported $0.33 earnings per share for the quarter, hitting analysts' consensus estimates of $0.33. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The company had revenue of $478.71 million during the quarter, compared to the consensus estimate of $462.01 million. During the same quarter last year, the firm earned $0.47 earnings per share. Analysts forecast that Astrana Health, Inc. will post 1.17 EPS for the current year.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.